Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma. (Q54730309)

3 June 2018

title

Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma. (English)

1 reference

3 June 2018

author

Viktória Lázár

1

1 reference

3 June 2018

author name string

Szilvia Ecsedi

2

1 reference

3 June 2018

Attila G Szöllosi

3

1 reference

3 June 2018

Réka Tóth

4

1 reference

3 June 2018

Laura Vízkeleti

5

1 reference

3 June 2018

Zsuzsa Rákosy

6

1 reference

3 June 2018

Agnes Bégány

7

1 reference

3 June 2018

Róza Adány

8

1 reference

3 June 2018

Margit Balázs

9

1 reference

3 June 2018

publication date

24 July 2009

1 reference

3 June 2018

published in

Modern Pathology

1 reference

3 June 2018

volume

22

1 reference

3 June 2018

issue

10

1 reference

3 June 2018

page(s)

1367-1378

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.109

exact match

0 references

cites work

Genetic progression of metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

DNA copy number alterations correlate with survival of esophageal adenocarcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Targeting the mitogen-activated protein kinase cascade to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Integrating BRAF/MEK inhibitors into combination therapy for melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

The new staging system for cutaneous melanoma in the era of lymphatic mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Mfold web server for nucleic acid folding and hybridization prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

RTPrimerDB: the real-time PCR primer and probe database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Rapid detection of VHL exon deletions using real-time quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Application of a modified real-time PCR technique for relative gene copy number quantification to the determination of the relationship between NKX3.1 loss and MYC gain in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Evaluation of quantitative polymerase chain reaction-based approaches for determining gene copy and gene transcript numbers in environmental samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Power analysis for real-time PCR quantification of genes in activated sludge and analysis of the variability introduced by DNA extraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Effects of creatine supplementation on housekeeping genes in human skeletal muscle using real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

BRAF and NRAS mutations in melanoma and melanocytic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

7 January 2021

Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

7 January 2021

EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

7 January 2021

Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1, 2 and 3 in the bovine species

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

7 January 2021

Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.109

7 January 2021

10.1038/MODPATHOL.2009.109

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

19633643

1 reference

3 June 2018